Psychemedics Corporation (PMD) News

Psychemedics Corporation (PMD)

Today's Latest Price: $5.86 USD

0.04 (0.69%)

Updated Jun 5 3:59pm

Add PMD to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 58 in Medical - Diagnostics/Research

See all "A" rated Strong Buy stocks

Filter PMD News Items

PMD News Results

Event/TimeSymbolCompanyNews DetailStartEndChangePOWR Rating
Loading, please wait...

Latest PMD News From Around the Web

Below are the latest news stories about Psychemedics Corp that investors may wish to consider to help them evaluate PMD as an investment opportunity.

Hedge Funds Are Selling Psychemedics Corp. (PMD)

At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW). In these volatile markets we scrutinize hedge fund filings to get a reading on which direction each […]

Yahoo | May 28, 2020

Does Psychemedics Corporation's (NASDAQ:PMD) CEO Pay Matter?

In 1991, Raymond Kubacki was appointed CEO of Psychemedics Corporation (NASDAQ:PMD). This analysis aims first to...

Yahoo | May 28, 2020

Psychemedics Announces First Quarter Results

ACTON, Mass., May 13, 2020 -- Psychemedics Corporation (NASDAQ:PMD) today announced first quarter financial results for the period ended March 31, 2020.  The Company’s revenue.

Yahoo | May 13, 2020

Psychemedics Announces a “Vaping Panel” to Detect and Deter the Use of Marijuana, CBD and Nicotine

Psychemedics Corporation (NASDAQ:PMD), the world leader and pioneer in detecting drugs of abuse using hair analysis, today introduced a Vaping Panel to detect the use of Marijuana, CBD and Nicotine. This test provides a way for schools and businesses to detect the ingestion of these drugs by all methods including electronic cigarettes or smoking. Hair testing provides several significant advantages over other methods of testing including a 90-day lookback period for the ingestion of drugs.

Yahoo | May 5, 2020

Psychemedics Test for Cotinine (metabolite of Nicotine) Detection Cleared by FDA

Psychemedics Corporation (NASDAQ:PMD), the world leader and pioneer in detecting drugs of abuse using hair analysis, today introduced the first FDA-cleared hair test for cotinine, the predominant metabolite for nicotine. This test provides a way for schools and businesses to detect the ingestion of nicotine by all methods including smoking or the use of electronic cigarettes. Hair testing provides several significant advantages over other methods of testing including a 90-day lookback period for the ingestion of drugs.

Yahoo | April 29, 2020

Psychemedics Corporation to Webcast 2020 Annual Meeting of Stockholders

Psychemedics Corporation (PMD) will hold its Annual Meeting of Stockholders (“Annual Meeting”) on Thursday, May 14, 2020 at 2:00 p.m. ET. Psychemedics Corporation has decided to hold the Annual Meeting in a virtual meeting format for this year, in light of public health concerns regarding the COVID-19 outbreak. As described in the proxy materials for the Annual Meeting, shareholders who held their shares as of the close of business on March 17, 2020, the record date, are entitled to vote in the Annual Meeting.

Yahoo | April 28, 2020

Should You Be Concerned About Psychemedics Corporation's (NASDAQ:PMD) Historical Volatility?

If you own shares in Psychemedics Corporation (NASDAQ:PMD) then it's worth thinking about how it contributes to the...

Yahoo | April 28, 2020

How Does Psychemedics's (NASDAQ:PMD) P/E Compare To Its Industry, After The Share Price Drop?

Unfortunately for some shareholders, the Psychemedics (NASDAQ:PMD) share price has dived 32% in the last thirty days...

Yahoo | April 2, 2020

What Is Psychemedics's (NASDAQ:PMD) P/E Ratio After Its Share Price Tanked?

Unfortunately for some shareholders, the Psychemedics (NASDAQ:PMD) share price has dived 35% in the last thirty days...

Yahoo | March 17, 2020

Psychemedics Corporation Announces 4th Quarter and Year-End Results

ACTON, Mass., Feb. 11, 2020 -- Psychemedics Corporation (NASDAQ:PMD) today announced fourth quarter and year-end financial results for the period ended December 31, 2019.  The.

Yahoo | February 11, 2020



Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.6759 seconds.